CLOV ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of April 6, 2021 in the Class Action Filed on Behalf of Clover Health Investments, Corp. Limited Shareholders

New York, New York--(Newsfile Corp. - February 15, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Clover Health Investments, Corp. (NASDAQ: CLOV) alleging that the Company violated federal securities laws.

Class Period: October 6, 2020 and February 3, 2021
Lead Plaintiff Deadline: April 6, 2021

Learn more about your recoverable losses in CLOV:
http://www.kleinstocklaw.com/pslra-1/clover-health-investments-corp-loss-submission-form?id=12898&from=5

The filed complaint alleges that Clover Health Investments, Corp. made materially false and/or misleading statements and/or failed to disclose that: (i) Clover was the recipient of a Civil Investigative Demand from the DOJ; (ii) much of Clover's sales are driven by a major related party deal that Clover not only failed to disclose but took active steps to conceal; (iii) Clover's subsidiary Seek Insurance failed to disclose its relationship with Clover and misled consumers as to its purported independence; (iv) Clover's software was in fact rudimentary; and (v) as a result, the Company's public statements were materially false and misleading at all relevant times.

Shareholders have until April 6, 2021 to petition the court for lead plaintiff status. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

For additional information about the CLOV lawsuit, please contact J. Klein, Esq. by telephone at 212-616-4899 or click the link above.

J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
J. Klein, Esq.
Empire State Building
350 Fifth Avenue
59th Floor
New York, NY 10118
jk@kleinstocklaw.com
Telephone: (212) 616-4899
Fax: (347) 558-9665
www.kleinstocklaw.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/74484